Toll样受体在1型糖尿病和糖尿病肾病发生发展中作用机制的研究进展

doi:10.13481/j.1671-587x.20170246

[1] Simmons K, Michels AW. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease[J]. Rheum Dis Clin North Am, 2014, 40(4):797-811.
[2] Liu R, Lee K, He JC.Genetics and epigenetics of diabetic nephropathy[J].Kidney Dis, 2015, 1(1):42-51.
[3] Mudaliar H, Pollock C, Ma J, et al.The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose[J].PLoS One, 2014, 9(10):e108844.
[4] Adamczak DM, Nowak JK, Frydrychowicz M, et al.The role of Toll-like receptors and vitamin D in diabetes mellitus type 1-a review[J].Scand J Immunol, 2014, 80(2):75-84.
[5] Medzhitov R, Preston-Hurlburt P, Janeway CA.A human homologue of the drosophila toll protein signals activation of adaptive immunity[J].Nature, 1997, 388(6640):394-397.
[6] Lin M, Tang SC.Toll-like receptors:sensing and reacting to diabetic injury in the kidney[J].Nephrol Dial Transplant, 2014, 29(4):746-754.
[7] Kokkinopoulos I, Jordan WJ, Ritter MA.Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes[J].Mol Immunol, 2005, 42(8):957-968.
[8] Grieco FA, Vendrame F, Spagnuolo I, et al.Innate immunity and the pathogenesis of type 1 diabetes[J].Semin Immunopathol, 2011, 33(1):57-66.
[9] Wen L, Ley RE, Volchkov PY, et al.Innate immunity and intestinal microbiota in the development of type 1 diabetes[J].Nature, 2008, 455(7216):1109-1113.
[10] Gale EA.The rise of childhood type 1 diabetes in the 20th century[J].Diabetes, 2002, 51(12):3353-3361.
[11] Roivainen M.Enteroviruses:new findings on the role of enteroviruses in type 1 diabetes[J].Int J Biochem Cell Biol, 2006, 38(5/6):721-725.
[12] Jaidane H, Hober D.Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes[J].Diabetes Metab, 2008, 34(6 Pt 1):537-548.
[13] Elshebani A, Olsson A, Westman J, et al.Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes[J].Virus Res, 2007, 124(1/2):193-203.
[14] Serreze DV, Ottendorfer EW, Ellis TM, et al.Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets[J].Diabetes, 2000, 49(5):708-711.
[15] Tracy S, Drescher KM, Chapman NM, et al.Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes:inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence[J].J Virol, 2002, 76(23):12097-12111.
[16] Richer MJ, Horwitz MS.Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes[J].Autoimmun Rev, 2009, 8(7):611-615.
[17] Dogusan Z, Garcia M, Flamez D, et al.Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways[J].Diabetes, 2008, 57(5):1236-1245.
[18] McCall KD, Thuma JR, Courreges MC, et al.Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice[J].Endocrinology, 2015, 156(2):453-461.
[19] Alkanani AK, Hara N, Lien E, et al.Induction of diabetes in the RIP-B7.1 mouse model is critically dependent on TLR3 and MyD88 pathways and is associated with alterations in the intestinal microbiome[J].Diabetes, 2014, 63(2):619-631.
[20] Kim HS, Han MS, Chung KW, et al.Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes[J].Immunity, 2007, 27(2):321-333.
[21] Kim F, Pham M, Luttrell I, et al.Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity[J].Circ Res, 2007, 100(11):1589-1596.
[22] Raveendran VV, Tan X, Sweeney ME, et al.Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells[J].Immunology, 2011, 132(4):578-588.
[23] Rajamani U, Jialal I.Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells:implications for diabetic retinopathy[J].J Diabetes Res, 2014, 2014:790902.
[24] Grishman EK, White PC, Savani RC.Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes[J].Pediatr Res, 2012, 71(6):626-632.
[25] Meyers AJ, Shah RR, Gottlieb PA, et al.Altered Toll-like receptor signaling pathways in human type 1 diabetes[J].J Mol Med (Berl), 2010, 88(12):1221-1231.
[26] Dasu MR, Devaraj S, Zhao L, et al.High glucose induces Toll-like receptor expression in human monocytes:mechanism of activation[J].Diabetes, 2008, 57(11):3090-3098.
[27] Dasu MR, Park S, Devaraj S, et al.Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice[J].Endocrinology, 2009, 150(8):3457-3464.
[28] Devaraj S, Tobias P, Kasinath BS, et al.Knockout of Toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy[J].Arterioscler Thromb Vasc Biol, 2011, 31(8):1796-1804.
[29] Devaraj S, Tobias P, Jialal I.Knockout of Toll-like receptor-4 attenuates the pro-inflammatory state of diabetes[J].Cytokine, 2011, 55(3):441-445.
[30] Devaraj S, Dasu MR, Rockwood J, et al.Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes:further evidence of a proinflammatory state[J].J Clin Endocrinol Metab, 2008, 93(2):578-583.
[31] Dasu MR, Devaraj S, Park S, et al.Increased Toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects[J].Diabetes Care, 2010, 33(4):861-868.
[32] Ladefoged M, Buschard K, Hansen AM.Increased expression of Toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes[J].APMIS, 2013, 121(6):531-538.
[33] Lin M, Yiu WH, Li RX, et al.The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy[J].Kidney Int, 2013, 83(5):887-900.
[34] Vives-Pi M, Rodríguez-Fernández S, Pujol-Autonell I.How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes:a review[J].Apoptosis, 2015, 20(3):263-272.
[35] Takata S, Sawa Y, Uchiyama T, et al.Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions[J].Acta Histochem Cytochem, 2013, 46(1):35-42.
[36] Wu C, Lv C, Chen F, et al.The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism[J].Mol Cell Endocrinol, 2015, 417:84-93.
[37] Pulskens WP, Rampanelli E, Teske GJ, et al.TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury[J].J Am Soc Nephrol, 2010, 21(8):1299-1308.
[38] Wolf G, Bohlender J, Bondeva T, et al.Angiotensin Ⅱ upregulates Toll-like receptor 4 on mesangial cells[J].J Am Soc Nephrol, 2006, 17(6):1585-1593.
[39] Musumeci D, Roviello GN, Montesarchio D.An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies[J].Pharmacol Ther, 2014, 141(3):347-357.

Progress research on mechanism of Toll-like receptors in occurrence and development of type 1 diabetes mellitus and diabetic nephropathy

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	PAN Hong, WANG Yufeng, HUANG Haipeng, ZHANG Liying, ZHONG Zhen, MA Shiqi, DONG Li, WANG Hongfeng. Influence of Adjust Zang Dredge Meridian electroacupuncture in expression of GRP78 in sciatic nerve cells of rats with diabetic peripheral neuropathy and its neuroprotective effect [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1124-1130.
[2]	QI Lu, BAI Wei, YU Weiying, LI Yuanyuan, HUA Wanqing, KOU Changgui. Randomized controlled trials for curative effect of saxagliptin combined with insulin in treatment of patients with type 2 diabetes mellitus: Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1235-1242.
[3]	QI Bingxue, SUN Yadong. A prospective study on primary prevention of major vascular lesions of type 2 diabetes mellitus patients in Han population in Northeast China [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1243-1248.
[4]	DONG Xuemei, WANG Lijuan, SHEN Hong, ZHAO Yan, ZHANG Xiujuan, QIAO Yue, CAI Hanqing. Application of insulin dose adjustment in blood glucose control in patients with type 2 diabetes treated by insulin pump [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1280-1285.
[5]	CHEN Yingbo, SONG Dan, WU Jin, JING Zuolei, LIU Liping, JIANG Rujiao, SUN Jie, WU Yingjie. Improvement effects of Dendrobium candidum on insulin resistance in MKR mice and MIN6 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 709-717.
[6]	HUANG Kaiwen, LI Arong, DENG Zhijun, LIU Ruoxuan, LI Changqing, ZHONG Shishun, GUO Jiewen, ZHANG Jie, CHEN Bin. Improvement effect of saponin of litchi seed on oxidative stress of pancreas tissue in impaired glucose regulation rats and its mechanism [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 746-752.
[7]	. Research progress in effects of DNA and histone epigenetic modifications in pathogenesis of type 2 diabetes [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 853-858.
[8]	WANG Haibin, DONG Zhijun, GUO Litao, SHI Jing, DONG Weili. Protective effect of Purendan Superfine Powder on retinopathy of rats with diabetes mellitus induced by streptozotocin and its influence in NF-κB signaling pathway [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 759-763.
[9]	SUN Zhumei, LIANG Weishi, KANG Jiali, MENG Xubing, WANG Jianxing, HAN Shuying. Dynamic pathological characteristics of kidney in db/db mice with type 2 diabetes mellitus [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 499-503.
[10]	. Research progress in expression of microRNA in differentiation process of stem cells into insulin producing cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 675-678.
[11]	PANG Chunyan, WANG Hui, WANG Zhihua, FENG Xiuyuan, WANG Yongfu. Effect of co-expression of IL-10 and sleeping beauty transposon on balance of Th17/Treg cells in splenocytes of NOD mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 205-210.
[12]	LIU Xiaojie, MEI Tao, MA Hongyan, YE Shandong. Analysis of influencing factors of carotid atherosclerosis plaque formation and stability in simple type 2 diabetic patients [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 350-355.
[13]	LI Chunhua, GUO Xin, DOU Jing, DING Mingxuan, YAO Yan, ZHANG Yanqiu. Survey analysis on cognitive dysfunction in patients with type 2 diabetes mellitus and its influecing factors [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 431-437.
[14]	WANG Jianxing, JIANG Yan, WANG Yan, WU Lei, MU Yu, HAN Shuying. Influence of extract from fermented buckwheat flower and leaf in kidney injury in type 2 diabetic db/db mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 95-100.
[15]	LI Cai, WEI Jie, ZHEN Yongzhan, DAI Minghe, HU Gang, GUO Lixin, LIN Yajun. Improvement effect of rhein lysinate on insulin resistance of KK/HlJ diabetic mice and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1074-1079.